Literature DB >> 19362041

PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation?

Shuang Pan1, Tie-Jun Li.   

Abstract

Mutations in PTCH1 gene are responsible for majority of nevoid basal cell carcinoma syndrome (NBCCS) as well as for some related sporadic neoplasms. Odontogenic keratocysts (OKCs) are locally aggressive jaw lesions that may occur in isolation or in association with NBCCS. Mutations of PTCH1 would lead to constitutive activation of Sonic hedgehog (SHH) signaling pathway and result in aberrant cell proliferation. To clarify the role of PTCH1 in OKCs, mutational analysis was undertaken in eight sporadic and four NBCCS-associated OKCs and six PTCH1 mutations were identified in two sporadic and three NBCCS-associated cases. The epithelial cell proliferation as assessed by Ki67 labeling was studied in a total cohort of 62 OKCs (42 sporadic and 20 syndromic cases) with known PTCH1 status. The epithelial Ki67 labeling in OKCs with PTCH1 mutation was significantly higher than that in cases with no PTCH1 mutation. Furthermore, OKCs harboring PTCH1 truncation-causing mutations showed an even greater Ki67 labeling index than those with non-truncation-causing mutations. These results suggest that PTCH1 mutations, particularly those causing protein truncations, are associated with a subgroup of OKCs showing increased proliferative activity and thus may relate to a phenotype of higher recurrent tendency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362041     DOI: 10.1016/j.oraloncology.2009.02.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Keratocystic Odontogenic Tumor (KCOT/OKC)-Clinical Guidelines for Resection.

Authors:  Gary Warburton; Amro Shihabi; Robert A Ord
Journal:  J Maxillofac Oral Surg       Date:  2015-01-04

Review 2.  The immunohistochemical profile of basal cell nevus syndrome-associated and sporadic odontogenic keratocysts: a systematic review and meta-analysis.

Authors:  Eleni-Marina Kalogirou; Grigorios Thermos; Vasileios Zogopoulos; Spyros Foutadakis; Ioannis Michalopoulos; Marios Agelopoulos; Konstantinos I Tosios
Journal:  Clin Oral Investig       Date:  2021-03-17       Impact factor: 3.573

3.  Molecular Signaling in Benign Odontogenic Neoplasia Pathogenesis.

Authors:  Hope M Amm; Mary MacDougall
Journal:  Curr Oral Health Rep       Date:  2016-03-31

4.  The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome.

Authors:  Mina S Ally; Jean Y Tang; Timmy Joseph; Bobbye Thompson; Joselyn Lindgren; Maria Acosta Raphael; Grace Ulerio; Anita M Chanana; Julian M Mackay-Wiggan; David R Bickers; Ervin H Epstein
Journal:  JAMA Dermatol       Date:  2014-05       Impact factor: 10.282

5.  Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour.

Authors:  Aline-Cristina-Batista-Rodrigues Johann; Patrícia-Carlos Caldeira; Marcelo-Vidigal Caliari; Ricardo-Santiago Gomez; Maria-Cássia-Ferreira Aguiar; Ricardo-Alves Mesquita
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-07-01

6.  Identification of the involvement of LOXL4 in generation of keratocystic odontogenic tumors by RNA-Seq analysis.

Authors:  Wei-Peng Jiang; Zi-Han Sima; Hai-Cheng Wang; Jian-Yun Zhang; Li-Sha Sun; Feng Chen; Tie-Jun Li
Journal:  Int J Oral Sci       Date:  2013-12-20       Impact factor: 6.344

Review 7.  PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review.

Authors:  Yan-Yan Guo; Jian-Yun Zhang; Xue-Fen Li; Hai-Yan Luo; Feng Chen; Tie-Jun Li
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

8.  Effect of the sonic hedgehog inhibitor GDC-0449 on an in vitro isogenic cellular model simulating odontogenic keratocysts.

Authors:  Jiemei Zhai; Heyu Zhang; Jianyun Zhang; Ran Zhang; Yingying Hong; Jiafei Qu; Feng Chen; Tiejun Li
Journal:  Int J Oral Sci       Date:  2019-01-05       Impact factor: 6.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.